Shuwen Biotech Appoint Dr. Barclay Li as Senior R&D Director
DEQING, CHINA, October 12, 2015 – Shuwen Biotech Co. Ltd., a diagnostic company focused on licensing, developing and commercializing diagnostic kits and services for unmet clinical needs in China, has announced today that it has appointed Dr. Barclay Li, an expert in in vitro diagnostics and a returnee from the UK, to serve as Senior Director of Diagnostic Development at Shuwen.
Dr. Li has more than ten years of experience in molecular diagnostic R&D. Prior to Shuwen, Dr. Li was a group leader of molecular biology at Sekisui Diagnostics (formerly Genzyme Diagnostics) in the UK. Previously, Dr. Li served as a manager at Thermo Fisher/Life Technologies leading its DNA Manufacturing and Contract Research group in Shanghai. Dr. Li was involved in the development of a number of molecular diagnostic IVD products for Influenza, MRSA, TB, among others.
“It’s great to have Barclay joining our team,” Stated Jay Z. Zhang, Chairman and CEO of Shuwen Biotech. “Dr. Li’s extensive experience in molecular diagnostics and in R&D management is valuable to Shuwen as we grow rapidly in molecular diagnostics through in-licensing and internal development.”
“It is a great pleasure to join the Shuwen team,” said Dr. Li. “Shuwen’s successful IP-based business strategy combining in-licensing and partnership with innovative internal development distinguishes itself from the pack in China. I am confident in Shuwen’s continuing leading position in the Chinese diagnostic industry and its ability to provide valuable diagnostics to physicians, patients, and the general public, and I am proud to be a part of that.”
Dr. Li received his Ph.D. in molecular biology from the University of Greenwich, UK, M.S. degree in biomedical sciences from the Peking Union Medical College, and B.S. in medicine from Hebei North University.
About Shuwen Biotech Co., Ltd.
Based in China, Shuwen Biotech is a diagnostic company providing China’s physicians and their patients with the most innovative diagnostic products and services to meet the growing need for improved prediction, prevention, diagnosis, prognosis, and treatment of diseases. The company is engaged in licensing, developing, marketing and distributing innovative diagnostic products and services for disease diagnosis and personalized medicine. Shuwen has capabilities for in vitro diagnostic kit (IVD) and laboratory-developed tests (LDT). Visit www.shuwenbiotech.com for more information.